Agentic AI aims to reduce this by leveraging technology in areas previously untouched, freeing up human resources for ...

Recruitment and retention remain two of the biggest challenges in Alzheimer’s and dementia clinical trials. Join Arun Singh, ...

Learn how streamlined confidentiality agreements and consistent workflows can speed site activation and improve sponsor-site transparency.

Ready to Lead the Way in AI-Driven Clinical Development? The clinical trial landscape is evolving at an incredible speed. The ...

Gain insight into how listening to site feedback and prioritizing engagement, training, and local patient understanding can drive smoother startups and stronger study outcomes.

Artificial intelligence (AI) offers a new path forward for clinical trial sponsors, contract research organizations (CROs), and research sites collaborating on trials. By replacing reactive protocols ...

Gain insight into how AI-powered agents can eliminate inefficiencies, shorten development timelines, and free clinical teams to focus on strategic decision-making.

Discover how early site involvement, streamlined training, and AI-driven tools can simplify system complexity and enhance ...

Reliable assay reproducibility is the bedrock of credible clinical trials, particularly in hemostasis diagnostics where ...

A look back at last week’s most-viewed content highlights how AI-driven monitoring could improve management of cytokine ...

In light of the recent US government shutdown, the National Institutes of Health (NIH) is rolling out a contingency staffing plan that will again affect funding. According to a statement released by ...

Steve Rosenberg, CEO, uMotif, discusses the challenges sites face with eCOA, eConsent, and ePRO platforms and the support ...